An effector phenotype of CD8+T cells at the junction epithelium during clinical quiescence of herpes simplex virus 2 infection

Journal of Virology

Volumn 86, Issue 19, 2012, Pages 10587-10596

  Peng, Tao ^a,b   Zhu, Jia ^a,b   Phasouk, Khamsone ^b   Koelle, David M ^a,b   Wald, Anna ^a,b   Corey, Lawrence ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR1; HERPES ANTIGEN; INTERLEUKIN 23; RANTES; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ADULT; ARTICLE; CCL5 GENE; CCR1 GENE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DERMOEPIDERMAL JUNCTION; FEMALE; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENITAL SYSTEM; GLUT 1 GENE; GZMB GENE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN TISSUE; IL 23 GENE; INFG GENE; LASER MICRODISSECTION; LTA GENE; LYMPHOCYTE SUBPOPULATION; MALE; PHENOTYPE; PRF1 GENE; PRIORITY JOURNAL; SKIN BIOPSY; SKIN EPITHELIUM; UPREGULATION;

ADULT; BIOPSY; CARBOHYDRATES; CD8-POSITIVE T-LYMPHOCYTES; EPIDERMIS; EPITHELIAL CELLS; FEMALE; HERPES SIMPLEX; HERPESVIRUS 2, HUMAN; HUMANS; LIPID METABOLISM; MALE; MIDDLE AGED; MODELS, GENETIC; MUCOUS MEMBRANE; PHENOTYPE; TRANSCRIPTION, GENETIC;

HERPES; HUMAN HERPESVIRUS 2; SIMPLEXVIRUS;

EID: 84869077019     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01237-12     Document Type: Article

References (30)

1. Albanesi C, et al. 2001. A cytokine-to-chemokine axis between T lymphocytes and keratinocytes can favor Th1 cell accumulation in chronic inflammatory skin diseases. J. Leukoc. Biol. 70:617-623.
2. Alsallaq RA, et al. 2010. Population level impact of an imperfect prophylactic vaccine for herpes simplex virus-2. Sex. Transm. Dis. 37:290-297.
3. Bartee E, Mohamed MR, Lopez MC, Baker HV, McFadden G. 2009. The addition of tumor necrosis factor plus beta interferon induces a novel synergistic antiviral state against poxviruses in primary human fibroblasts. J. Virol. 83:498-511.
4. Bruckner BA, Ammini CV, Otal MP, Raizada MK, Stacpoole PW. 1999. Regulation of brain glucose transporters by glucose and oxygen deprivation. Metabolism 48:422-431.
5. Catalfamo M, et al. 2004. Human CD8+ T cells store RANTES in a unique secretory compartment and release it rapidly after TcR stimulation. Immunity 20:219-230.
6. Chakrabarti R, Jung CY, Lee TP, Liu H, Mookerjee BK. 1994. Changes in glucose transport and transporter isoforms during the activation of human peripheral blood lymphocytes by phytohemagglutinin. J. Immunol. 152:2660-2668.
7. Curiel R, Garcia C, Farooq L, Aguero M, Espinoza-Delgado I. 2001. Bryostatin-1 and IL-2 synergize to induce IFN-γ expression in human peripheral blood T cells: implications for cancer immunotherapy. J. Immunol. 167:4828-4837.
8. Evans R, et al. 2009. Integrins in immunity. J. Cell Sci. 122:215-225.
9. Frauwirth KA, Thompson CB. 2004. Regulation of T lymphocyte metabolism. J. Immunol. 172:4661-4665.
10. Homey B, et al. 2002. CCL27-CCR10 interactions regulate T cellmediated skin inflammation. Nat. Med. 8:157-165.
11. Jones RG, Thompson CB. 2007. Revving the engine: signal transduction fuels T cell activation. Immunity 27:173-178.
12. Kaech SM, et al. 2003. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4:1191-1198.
13. Koelle DM, et al. 2002. Expression of cutaneous lymphocyte-associated antigen by CD8(+) T cells specific for a skin-tropic virus. J. Clin. Invest. 110:537-548.
14. Koelle DM, et al. 1998. Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes. J. Clin. Invest. 101:1500-1508.
15. Lacorazza HD, et al. 2002. The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells. Immunity 17:437-449.
16. Lin L, Spoor MS, Gerth AJ, Brody SL, Peng SL. 2004. Modulation of Th1 activation and inflammation by the NF-kappaB repressor Foxj1. Science 303:1017-1020.
17. Magaret A, Wald A, Huang ML, Selke S, Corey L. 2007. Optimizing PCR positivity criterion for detection of herpes simplex virus DNA on skin and mucosa. J. Clin. Immunol. 45:1618-1620.
18. Mark KE, et al. 2008. Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults. J. Infect. Dis. 198:1141-1149.
19. Michalek RD, Rathmell JC. 2010. The metabolic life and times of a T-cell. Immunol. Rev. 236:190-202.
20. Morrow R, Friedrich D, Meier A, Corey L. 2005. Use of "Biokit HSV-2 rapid assay" to improve the positive predictive value of Focus HerpeSelect HSV-2 ELISA. BMC Infect. Dis. 5:84.
21. Peng T, Zhu J, Hwangbo Y, Corey L, Bumgarner RE. 2008. Independent and cooperative antiviral actions of beta interferon and gamma interferon against herpes simplex virus replication in primary human fibroblasts. J. Virol. 82:1934-1945.
22. Peng T, et al. 2009. Evasion of the mucosal innate immune system by herpes simplex virus type 2. J. Virol. 83:12559-12568.
23. Sato K, Kawasaki H, Morimoto C, Yamashima N, Matsuyama T. 2002. An abortive ligand-induced activation of CCR1-mediated downstream signaling event and a deficiency of CCR5 expression are associated with the hyporesponsiveness of human naive CD4+ T cells to CCL3 and CCL5. J. Immunol. 168:6263-6272.
24. Schiffer JT, Wald A, Selke S, Corey L, Magaret A. 2011. The kinetics of mucosal herpes simplex virus-2 infection in humans: evidence for rapid viral-host interactions. J. Infect. Dis. 204:554-561.
25. Wald A, et al. 1997. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J. Clin. Invest. 99:1092-1097.
26. Wu L, et al. 1997. Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding. J. Exp. Med. 186:1373-1381.
27. Zepp JA, Nold-Petry CA, Dinarello CA, Nold MF. 2011. Protection from RNA and DNA viruses by IL-32. J. Immunol. 186:4110-4118.
28. Zhu J, et al. 2009. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat. Med. 15:886-892.
29. Zhu J, et al. 2007. Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation. J. Exp. Med. 204:595-603.
30. Zlotnik A, Yoshie O. 2000. Chemokines: a new classification system and their role in immunity. Immunity 12:121-127.